Double-Sided Personality: Effects of Arsenic Trioxide on Inflammation
- 9 April 2018
- journal article
- review article
- Published by Springer Nature in Inflammation
- Vol. 41 (4) , 1128-1134
Abstract
In 1992, arsenic trioxide (As2O3, ATO) was demonstrated to be an effective therapeutic agent against acute promyelocytic leukemia (APL), rekindling attention to ATO applications in U.S. Food and Drug Administration clinical trials for the treatment of cancers, such as leukemia, lymphomas, and solid tumors. ATO is a potent chemotherapeutic drug that can also be used to treat other diseases, such as autoimmune diseases, because it affects multiple pathways including apoptosis induction, differentiation stimulation, and proliferation inhibition. As inflammation is a critical component of disease progression, ATO is a feasible treatment option based on its ability to protect against inflammation. However, ATO is also a well-known carcinogen because of its pro-inflammatory effect. This review will focus on the double-sided effects of ATO on inflammation as well as the relevant mechanisms underlying these effects, aiming to provide a rational understanding of how ATO effects the immune system. We especially aim to provide a comprehensive overview of our current knowledge of how ATO influences inflammation.Keywords
Funding Information
- National Natural Science Foundation of China (NSFC 81771749)
This publication has 51 references indexed in Scilit:
- Influence of anticancer agents on cell survival, proliferation, and CD4+CD25+Foxp3+ regulatory T cell-frequency in human peripheral-blood mononuclear cells activated by T cell-mitogenInternational Immunopharmacology, 2013
- Anti-Inflammatory Effects of Arsenic Trioxide Eluting Stents in a Porcine Coronary ModelBioMed Research International, 2013
- Aberrantly Expressed Genes in HaCaT Keratinocytes Chronically Exposed to Arsenic TrioxideBiomarker Insights, 2011
- Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activationInnate Immunity, 2010
- Arsenic trioxide alleviates airway hyperresponsiveness and eosinophilia in a murine model of asthmaCellular & Molecular Immunology, 2010
- Evidence that endoplasmic reticulum (ER) stress and caspase-4 activation occur in human neutrophilsBiochemical and Biophysical Research Communications, 2010
- Immunotoxicity and biodistribution analysis of arsenic trioxide in C57Bl/6 mice following a 2-week inhalation exposureToxicology and Applied Pharmacology, 2009
- Differential regulation and properties of MAPKsOncogene, 2007
- Sustained activation of c‐jun‐N‐terminal kinase plays a critical role in arsenic trioxide‐induced cell apoptosis in multiple myeloma cell linesCancer Science, 2006
- Inflammation and cancerNature, 2002